Equibles does not estimate personal net worth.
Get an email with a short summary when Idexx Laboratories Inc publishes a filing, an earnings call transcript or a press release.
Get IDXX alertsJay Mazelsky is recorded as CEO at Idexx Laboratories Inc (IDXX). Jay Mazelsky has spoken on 22 earnings calls across 1 company, most recently for Idexx Laboratories Inc on May 5, 2026. Idexx Laboratories Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Idexx Laboratories Inc includes Jonathan Mazelsky (CEO), Michael (Mike) Erickson (CEO and Board Member), Michael (Mike) Erickson, PhD (CEO and Board Member) and 7 others.
“IDEX delivered an exceptional start to 2026. with first quarter results reflecting disciplined commercial execution, continued benefits from innovation, and expanded diagnostics utilization across a global customer base.”
“IDEXX delivered a very strong fourth quarter closing a year marked by exceptional execution across the organization and meaningful strategic progress towards our long-term potential.”
“IDEXX delivered very strong financial performance in the third quarter while advancing our strategic priorities globally.”
“2025 is off to a solid start as IDEXX's innovations gain commercial traction across the portfolio. At the end of March, we launched IDEXX Cancer Dx through our reference labs in North America.”
“IDEXX delivered another strong quarter to close out 2024, capped with the initial placements of IDEXX inVue Dx.”
Diagnostics & Research · Healthcare
CEO
